285 filings
Page 4 of 15
6-K
ct3s21i8h8q9
4 Nov 21
Report of Foreign Private Issuer
8:01am
6-K
4rtr9 2ao
11 Aug 21
Kamada Reports Second Quarter and First Half 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:02am
6-K
2i7nq
5 Aug 21
Report of Foreign Private Issuer
8:12am
6-K
dn4b 2w11
2 Jun 21
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children
7:08am
6-K
fg8 ol8tgil6h0pdc8h
12 May 21
Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:06am
6-K
5focrajt5j 72
5 May 21
Report of Foreign Private Issuer
7:16am
6-K
xis ekso6e
7 Apr 21
Kamada Announces Amendment to GLASSIA® License Agreement with Takeda
7:01am
6-K
5mscjjms 6bbo
31 Mar 21
Report of Foreign Private Issuer
6:01am
6-K
e6xu028gxj u5he
9 Mar 21
Kamada to Present at the Jefferies Global Plasma Summit
7:00am
6-K
4fq o4ou9
3 Mar 21
Transaction Furthers Kamada’s Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company
7:00am
6-K
a96p7ybaf
24 Feb 21
Report of Foreign Private Issuer
7:01am
6-K
gj0gc609at
10 Feb 21
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
7:00am
6-K
8e8l7xf
3 Feb 21
Report of Foreign Private Issuer
7:03am
6-K
wdd x7gm7oq
1 Feb 21
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
7:00am
6-K
q4m995l 7xr8up529
13 Jan 21
Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel
7:00am
6-K
yu354ry0456
5 Jan 21
Report of Foreign Private Issuer
7:00am
6-K
nujcs
29 Dec 20
Report of Foreign Private Issuer
7:01am
6-K
dqm lockm
21 Dec 20
Kamada Added to the NASDAQ Biotechnology Index
7:01am
6-K
z9bxt5u
15 Dec 20
Report of Foreign Private Issuer
7:05am
6-K
dbquee ym
10 Dec 20
Report of Foreign Private Issuer
9:30am